P
Prestige Biologics Co Ltd
KOSDAQ:334970
Prestige Biologics Co Ltd
KOSDAQ:334970
Price:
2 760
KRW
-1.25%
Market Closed
Market Cap:
₩214.6B
Relative Value
The Relative Value of one Prestige Biologics Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 2 760 KRW, Prestige Biologics Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Prestige Biologics Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Prestige Biologics Co Ltd Competitors
Prestige Biologics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
P
|
Prestige Biologics Co Ltd
KOSDAQ:334970
|
214.6B KRW | 16.1 | -6.3 | -9.9 | -6.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
412.3B USD | 6.7 | 98.4 | 16.1 | 22.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
207.4B USD | 5.6 | 26.7 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.4B USD | 6.3 | 21.8 | 13.6 | 16.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.9B USD | 10.3 | 31.4 | 23.7 | 24.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD | 5.8 | 18.4 | 13.9 | 15.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.3 | 36 | 11.8 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.8B EUR | 11.3 | 36.3 | 39.6 | 40.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
